NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Forecast, Price & News

$5.97

-0.15 (-2.45%)

(As of 05/30/2023 ET)

Compare

Today's Range: $5.86
▼
$6.27
50-Day Range: $2.48
▼
$8.64
52-Week Range: $1.18
▼
$9.69

Volume: 70,074 shs
Average Volume: 88,775 shs
Market Capitalization: $224.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Pulse Biosciences MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
28.14% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.60
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: Acquiring Shares
$65.25 M Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.83 out of 5 stars

Medical Sector

834th out of 1,009 stocks

Surgical & Medical Instruments Industry

84th out of 104 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pulse Biosciences.

2.0

Short Interest

Percentage of Shares Shorted
28.14% of the float of Pulse Biosciences has been sold short.
Short Interest Ratio / Days to Cover
Pulse Biosciences has a short interest ratio ("days to cover") of 16.3, which indicates bearish sentiment.
Change versus previous month
Short interest in Pulse Biosciences has recently decreased by 6.15%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Pulse Biosciences does not currently pay a dividend.
Dividend Growth
Pulse Biosciences does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Pulse Biosciences has received a 61.90% net impact score from Upright. Pulse Biosciences seems to create the most significant positive value in categories "Jobs", "Physical diseases", and "Taxes". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Diagnostic and treatment machines", "Medical devices engineering", and "Clinical research services for cancer" products. See details.
Environmental Sustainability
The Environmental Impact score for Pulse Biosciences is -0.60.

3.3

News and Social Media Coverage

News Sentiment
Pulse Biosciences has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Pulse Biosciences this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for PLSE on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
MarketBeat Follows
4 people have added Pulse Biosciences to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pulse Biosciences insiders have bought more of their company's stock than they have sold. Specifically, they have bought $65,249,320.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
55.00% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 6.56% of the stock of Pulse Biosciences is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Pulse Biosciences is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pulse Biosciences is -4.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Pulse Biosciences (NASDAQ:PLSE) Stock

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

May 22, 2023 | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Coverage Initiated at StockNews.com

May 18, 2023 | finance.yahoo.com

Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting

May 30, 2023 | Legacy Research (Affiliate) (Ad)

The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty

A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.

May 17, 2023 | markets.businessinsider.com

Maxim Group Sticks to Their Hold Rating for Pulse Biosciences (PLSE)

May 16, 2023 | finance.yahoo.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2023 Earnings Call Transcript

May 12, 2023 | finance.yahoo.com

Q1 2023 Pulse Biosciences Inc Earnings Call

May 11, 2023 | msn.com

Recap: Pulse Biosciences Q1 Earnings

May 11, 2023 | finance.yahoo.com

Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results

May 30, 2023 | MarketBeat Internal (Ad)

Introducing MarketBeat All Access

Get real-time financial news and market data with MarketBeat All Access. Monitor your portfolio and the markets. Access our top stock picks, unbeatable research tools, best-in-class stock screeners, and proprietary research reports.

May 11, 2023 | americanbankingnews.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Robert W. Duggan Purchases 10,022,937 Shares of Stock

May 10, 2023 | msn.com

Pulse Biosciences to notify planned redemption of warrants

May 10, 2023 | finance.yahoo.com

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

May 9, 2023 | americanbankingnews.com

Pulse Biosciences (PLSE) to Release Earnings on Thursday

May 6, 2023 | marketwatch.com

8-K: Pulse Biosciences, Inc.

May 5, 2023 | benzinga.com

Pulse Biosciences Chief Executive Officer Awarded $3.73M Worth of Stock Options

May 3, 2023 | finance.yahoo.com

Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer

May 1, 2023 | finance.yahoo.com

Pulse Biosciences Announces $65 Million Private Placement

April 27, 2023 | finance.yahoo.com

Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023

April 21, 2023 | americanbankingnews.com

Analyzing Pulse Biosciences (NASDAQ:PLSE) and Paragon 28 (NYSE:FNA)

April 20, 2023 | finance.yahoo.com

As Pulse Biosciences, Inc. (NASDAQ:PLSE) hits US$217m market cap, insiders may be dismayed about not purchasing higher quantities

April 6, 2023 | americanbankingnews.com

Financial Analysis: Pulse Biosciences (NASDAQ:PLSE) & Apollo Endosurgery (NASDAQ:APEN)

April 6, 2023 | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.com

April 5, 2023 | finance.yahoo.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2022 Earnings Call Transcript

April 1, 2023 | americanbankingnews.com

Pulse Biosciences (NASDAQ:PLSE) Posts Earnings Results

March 30, 2023 | finance.yahoo.com

Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results

March 29, 2023 | markets.businessinsider.com

Pulse Biosciences is about to announce its earnings — here's what Wall Street expects

March 29, 2023 | msn.com

A Preview Of Pulse Biosciences's Earnings

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Company Calendar

Last Earnings: 5/11/2023
Today: 5/30/2023
Next Earnings (Estimated): 8/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PLSE
CUSIP: N/A
CIK: 1625101
Web: www.pulsebiosciences.com
Phone: (510) 906-4600
Fax: N/A
Employees: 142
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.44)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-58,510,000.00
Net Margins: N/A
Pretax Margin: -19,934.77%
Return on Equity: -1,185.19%
Return on Assets: -71.59%

Debt

Debt-to-Equity Ratio: 10.50
Current Ratio: 7.86
Quick Ratio: 7.86

Sales & Book Value

Annual Sales: $700,000.00
Price / Sales: 321.02
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.06) per share
Price / Book: -99.50

Miscellaneous

Outstanding Shares: 37,640,000
Free Float: 16,939,000
Market Cap: $224.71 million
Optionable: Optionable
Beta: 1.13

Key Executives

Kevin P. Danahy
President, Chief Executive & Financial Officer

Edison Manuel
Vice President-Operations

Darrin R. Uecker
Director & Chief Technology Officer

David Danitz
Senior Vice President-Engineering

Dunnington Gansevoort
Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PLSE Stock - Frequently Asked Questions

Should I buy or sell Pulse Biosciences stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PLSE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PLSE, but not buy additional shares or sell existing shares.
View PLSE analyst ratings or view top-rated stocks.
How have PLSE shares performed in 2023?: Pulse Biosciences' stock was trading at $2.77 at the beginning of the year. Since then, PLSE shares have increased by 115.5% and is now trading at $5.97.
View the best growth stocks for 2023 here.
When is Pulse Biosciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our PLSE earnings forecast.
How were Pulse Biosciences' earnings last quarter?: Pulse Biosciences, Inc. (NASDAQ:PLSE) released its quarterly earnings data on Thursday, May, 11th. The company reported ($0.25) earnings per share for the quarter.
What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO?: 2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Pulse Biosciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA), Portola Pharmaceuticals (PTLA), Enphase Energy (ENPH) and Novavax (NVAX).

When did Pulse Biosciences IPO?: (PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.
What is Pulse Biosciences' stock symbol?: Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."
Who are Pulse Biosciences' major shareholders?: Pulse Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include Bank of America Corp DE (2.06%), Griffin Asset Management Inc. (0.45%), Geode Capital Management LLC (0.38%), Westside Investment Management Inc. (0.30%), Spotlight Asset Group Inc. (0.18%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Kevin Patrick Danahy, Maky Zanganeh, Mitchell E Levinson and Robert W Duggan.
View institutional ownership trends.
How do I buy shares of Pulse Biosciences?: Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Pulse Biosciences' stock price today?: One share of PLSE stock can currently be purchased for approximately $5.97.
How much money does Pulse Biosciences make?: Pulse Biosciences (NASDAQ:PLSE) has a market capitalization of $224.71 million and generates $700,000.00 in revenue each year. The company earns $-58,510,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.
How many employees does Pulse Biosciences have?: The company employs 142 workers across the globe.
How can I contact Pulse Biosciences?: Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The official website for the company is www.pulsebiosciences.com. The company can be reached via phone at (510) 906-4600 or via email at ir@pulsebiosciences.com.

This page (NASDAQ:PLSE) was last updated on 5/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Pulse Biosciences (PLSE) Stock Forecast, Price & News

Pulse Biosciences MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month